BiotechTube
Home/Syros Pharmaceuticals/Eric R. Olson
ER

Eric R. Olson

Chief Scientific Officer, Co-founder

Syros Pharmaceuticals

Therapeutic Areas

Oncology

Syros Pharmaceuticals Pipeline

DrugIndicationPhase
Tamibarotene (SY-1425)RARA-positive Higher-Risk MDSPhase 3
SY-2101Acute Promyelocytic Leukemia (APL)Phase 3
SY-5609Solid TumorsPhase 1/2
SY-5007RET-altered Solid TumorsPreclinical

Leadership Team at Syros Pharmaceuticals

CC
Conley Chee
Chief Executive Officer
DA
David A. Roth
Chief Medical Officer
JH
Jason Haas
Chief Financial Officer
MK
Marcin Kortylewski
Board Member
KA
Keith A. Katkin
Board Member
NS
Nancy Simonian
Former Chief Executive Officer
View full Syros Pharmaceuticals profile